4//SEC Filing
GOWEN MAXINE 4
Accession 0001415889-24-016195
CIK 0001557746other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:15 PM ET
Size
8.0 KB
Accession
0001415889-24-016195
Insider Transaction Report
Form 4
GOWEN MAXINE
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 totalExercise: $1.03Exp: 2034-06-05→ Common Stock (15,750 underlying) - Award
Restricted Stock Units
2024-06-06+4,793→ 4,793 total→ Common Stock (4,793 underlying)
Footnotes (4)
- [F1]The shares subject to this option will vest in twelve equal monthly installments commencing July 6, 2024, subject to Reporting Person's continuous service through each such date.
- [F2]This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F4]The shares underlying these restricted stock units will vest on June 6, 2025, subject to the Reporting Person's continuous service through such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001280044
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:15 PM ET
- Size
- 8.0 KB